Diadema Partners »

BioCryst Pharmaceuticals shares owned by Diadema Partners

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.5M 191k 7.80

More positions owned by Diadema Partners

Viking Therapeutics (VKTX)
Vertex Pharmaceuticals Incorporated (VRTX)
Bridgebio Pharma (BBIO)
Spdr Series Trust State Street Spd Put Option (XBI)
Praxis Precision Medicines I Com New Put Option (PRAX)
Johnson & Johnson (JNJ)
Avidity Biosciences Ord Call Option (RNA)
Capricor Therapeutics Com New (CAPR)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Jazz Pharmaceuticals Shs Usd Call Option (JAZZ)
Terns Pharmaceuticals (TERN)
Apogee Therapeutics Call Option (APGE)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Regeneron Pharmaceuticals (REGN)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Diadema Partners

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
BlackRock
Deerfield Management Company
State Street Corporation
Kynam Capital Management
Alkeon Capital Management
UBS Group
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Nuveen
Goldman Sachs Group
Jennifer Ranahan
Eversept Partners
Bnp Paribas Arbitrage, Snc

View all funds holding BioCryst Pharmaceuticals